A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2002
12/03/2002	US6489320 5, 5-disubstituted-1, 5-dihydro-4, 1-benzoxazepin-2 (3H)-ones useful as HIV reverse transcriptase inhibitors
12/03/2002	US6489318 Ethylidene derivatives of tricyclic carbapenems
12/03/2002	US6489296 Treatment of hypercoagulable states or acquired protein c deficiency with activated protein c, a highly selective therapeutic agent with a low potential for causing bleeding complications
12/03/2002	US6489295 Antagonists of intestinotrophic GLP-2 peptides
12/03/2002	US6488969 Method for reducing blood ammonia concentration
12/03/2002	US6488953 Oral transmucosal delivery
12/03/2002	US6488951 Stable NO-delivering compounds
12/03/2002	US6488936 Glycoprotein d of herpes simplex type i and type ii
12/03/2002	US6488665 Antimicrobial alcohol gel pre-operative skin-preparation delivery system
12/03/2002	US6488032 Method of providing cosmetic/medical therapy
12/03/2002	CA2414000A1 Pyridin-2-ylaminoalkylcarbonylglycyl-beta-alanine and derivatives
12/03/2002	CA2255748C Uridine-comprising therapeutic active agent for treatment of neurodegenerative disorders
12/03/2002	CA2126103C Transfection of lung via aerosolized transgene delivery
11/2002
11/30/2002	CA2387821A1 Azalide antibiotic compositions
11/28/2002	WO2002095417A2 PRE-mRNA SPLICING SCREENING ASSAY
11/28/2002	WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095036A2 A novel intein and uses thereof
11/28/2002	WO2002095029A2 Nucleic acid and protein sequences of bovine epidermal growth factor
11/28/2002	WO2002095023A2 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
11/28/2002	WO2002095015A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002095007A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002	WO2002094875A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION
11/28/2002	WO2002094874A2 Internalisation of virus into cells
11/28/2002	WO2002094868A2 Staphylococcus aureus proteins and nucleic acids
11/28/2002	WO2002094863A2 INTERFERON-α INDUCED GENE
11/28/2002	WO2002094858A1 Antiviral compounds derived from the non-glycosylated central subdomain of respiratory syncytial virus (rsv) protein g.
11/28/2002	WO2002094844A2 Antiviral nucleosides
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094832A1 New benzylaminopyrimidines
11/28/2002	WO2002094831A1 Novel pyridylmethylaminopyrimidines
11/28/2002	WO2002094829A1 Carbapenem compound
11/28/2002	WO2002094828A1 Process for the preparation of imipenem
11/28/2002	WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002	WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094814A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
11/28/2002	WO2002094796A2 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
11/28/2002	WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002	WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002	WO2002094754A1 Vitamin d analogues
11/28/2002	WO2002094342A2 Compositions for protein delivery via the pulmonary route
11/28/2002	WO2002094322A2 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug
11/28/2002	WO2002094317A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists
11/28/2002	WO2002094314A1 Tsg101 as inhibitor of hiv production
11/28/2002	WO2002094313A2 Vaccine composition
11/28/2002	WO2002094300A1 Herbal compositions for the treatment of mucosal lesions
11/28/2002	WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002	WO2002094289A1 Antiviral nucleoside derivatives
11/28/2002	WO2002094287A2 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002	WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002	WO2002094250A2 Therapeutic uses of lna-modified oligonucleotides in infectious diseases
11/28/2002	WO2002094236A1 Delivery of antipsychotics through an inhalation route
11/28/2002	WO2002094221A1 Emulsion and dispersion formulations and method
11/28/2002	WO2002094217A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002	WO2002094190A2 Heterologous protection induced by immunization with invaplex vaccine
11/28/2002	WO2002094189A2 Compositions and methods for treating or preventing convulsions or seizures
11/28/2002	WO2002094188A2 Methods for regulating bacteria
11/28/2002	WO2002094185A2 Conjugates and compositions for cellular delivery
11/28/2002	WO2002094180A2 Pharmaceutically active isoindoline derivatives
11/28/2002	WO2002094019A1 Highly purified antiendotoxin compound
11/28/2002	WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002080648A3 Mucosal boosting following parenteral priming
11/28/2002	WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002062777A3 Amino ceramide-like compounds and therapeutic methods of use
11/28/2002	WO2002045745A3 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis
11/28/2002	WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002	WO2002036733A3 Cd36 as a heat shock protein receptor and uses thereof
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001096329A1 Medicinal compositions containing propenone derivatives
11/28/2002	WO2001095919A3 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
11/28/2002	WO2001082897A3 Liposome drug delivery
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020178456 Polyclonal antibodies for use inthe treatment and prevention of bacteria, fungi, virus and parasites infections
11/28/2002	US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002	US20020177839 Microprojection array having a beneficial agent containing coating
11/28/2002	US20020177707 Aminoaryl oxazolidinone n-oxides
11/28/2002	US20020177703 Novel crystalline forms of an antiviral benzimidazole compound
11/28/2002	US20020177618 ERK (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
11/28/2002	US20020177609 Fatty alcohol drug conjugates
11/28/2002	US20020177604 N-(4-chlorobenzyl)-6-(3-hydroxy-1-propynyl)-1-7-dimethyl-4-oxo-1,4 -dihydro(1,8)naphthyridine-3-carboxamide for example; inhibiting viral DNA polymerase; treating herpes virus infections
11/28/2002	US20020177603 5,10-dihydrobenzo(b)(1,8)naphthyridine compounds, N-oxides; 3,7-Dichloro-5-isopropoxymethyl-5-trifluoromethyl-5,10 -dihydrobenzo(b)(1,8)naphthyridine for example; combination therapy
11/28/2002	US20020177591 Central nervous system (CNS); diazabicyclo compounds such as 1,4-Diaza-bicyclo(3.2.2)nonane-4-carboxylic acid, 4-cyclohexyl-phenyl ester; CNS-penetrant alpha 7 nicotinic receptor agonist
11/28/2002	US20020177562 Dissolving in an acidified solvent and spray-drying to form a powder suitable for oral inhalation to the lung
11/28/2002	US20020177213 Tissue plasminogen activator-like protease
11/28/2002	US20020176894 For an azole antifungal or antibacterial drug; core and a drug emulsion layer containing the drug, an emulsifier, binder and absorbent aid such as citric acid; solubility, bioavailability
11/28/2002	US20020176886 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
11/28/2002	US20020176885 Given concentration of halide-comprising salts such as sodium chloride; nonirritating antiseptic; can be used in eyes
11/28/2002	US20020176871 A nucleic acids encoding an intracellular mature virion antigen and at least one nucleic acid encoding an extracellular enveloped virion antigen of a poxvirus
11/28/2002	US20020176869 Hepatitus A virus vaccines
11/28/2002	US20020176861 A phosphate derivative when co-administered with antigens such as vaccines for bacterial and viral diseases function as immunological adjuvant
11/28/2002	US20020176818 Radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid

1 ... 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 ... 1798